Théa, OliX to develop RNAi therapies for AMD treatment
Korea | News | 0 Comment | 18 Mar, 2019
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and col...Read more
ResMed completes acquisition of HB Healthcare
Korea | News | 0 Comment | 14 Mar, 2019
ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has announced ...Read more
Medical Korea 2019 to explore global healthcare era
Korea | News | 0 Comment | 06 Mar, 2019
The global healthcare and medical tourism conference "Medical Korea 2019" will be held for three days from March 14 at G...Read more
Can-Fite expands its Namodenoson Distribution Deal with CKD
Korea | News | 0 Comment | 27 Feb, 2019
Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer...Read more
ABL Bio, WuXi Bio expand strategic collaboration for $220M
Korea | News | 0 Comment | 26 Feb, 2019
WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...Read more
Xynomic Pharma doses first South Korean patient in Phase 3 RCC trial
Korea | News | 0 Comment | 25 Feb, 2019
Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp.jointly ...Read more
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Korea | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...Read more
Korean govt to inject $2.6B to develop biotech in 2019
Korea | News | 0 Comment | 20 Feb, 2019
According to reports from the Korean Herald, the government of Korea will spend 2.93 trillion won (US$2.61 billion...Read more
ROKIT brings innovative 3D bioprinting strategy for skin regeneration
Korea | News | 0 Comment | 20 Feb, 2019
ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic str...Read more
SK Biopharma to take antiepileptic drug to Europe
Korea | News | 0 Comment | 18 Feb, 2019
SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing ag...Read more
Bridge Bio presents Preclinical, Ph I study results for BBT-401
Korea | News | 0 Comment | 12 Feb, 2019
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the...Read more
OliX announces clinical candidate for Geographic Atrophy treatment
Korea | News | 0 Comment | 29 Jan, 2019
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...Read more
US FDA approves Samsung Bioepis' first oncology drug
Korea | News | 0 Comment | 21 Jan, 2019
Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencin...Read more
Bridge Bio receives FDA ODD for IPF drug
Korea | News | 0 Comment | 17 Jan, 2019
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...Read more
Glenmark enters commercialization agreement with Yuhan Corp
Korea | News | 0 Comment | 10 Jan, 2019
Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has announced that its Suisse su...Read more
Norgine, Korea Pharma ink deal to commercialise PLENVU in Korea
Korea | News | 0 Comment | 08 Jan, 2019
NORGINE B.V. (Norgine), a leading European specialty pharmaceutical company and KOREA PHARMA CO., LTD. (Korea Pharma), a...Read more
Gilead Sciences, Yuhan to treat advanced fibrosis due to NASH
Korea | News | 0 Comment | 07 Jan, 2019
Gilead Sciences, Inc. and Yuhan Corporation has announced that the companies have entered into a licensing and collabora...Read more
South Korea IVD Market 2017-2022; overview by ResearchAndMarkets
Korea | News | 0 Comment | 02 Jan, 2019
South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, ...Read more